Erowid References Database
|
Obrocki J, Buchert R, Vaterlein O, Thomasius R, Beyer W, Schiemann T.
“Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography”.
Br J Psychiatry. 1999 Aug;175:186-8.
|
|
Abstract
BACKGROUND: The main psychotropic agent of the popular illicit drug ecstasy is 3,4-methylenedioxymethamphetamine (MDMA). In the light of animal studies and examinations of human cerebrospinal fluid, MDMA is suspected of causing neurotoxic lesions to the serotonergic system. AIMS: To postulate a relationship between ecstasy use and lasting alterations to the cerebral glucose metabolic rate.
METHODS: Positron emission tomography (PET) with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) was performed on seven ecstasy users and seven subjects without any known history of illicit drug use. Data were compared for a limited number of brain regions.
RESULTS: By comparison with the control group, the glucose metabolic uptake of the ecstasy user group was altered within the amygdala, hippocampus and Brodmann's area II. CONCLUSIONS: The results suggest the possibility that ecstasy use has lasting effects on central neuronal activity in humans.
|
| # |
| Submit Comment |
|
[
Cite HTML ]
